Characteristics of boningmycin induced cellular senescence of human tumor cells

Yaoxue Xuebao

Volumn 45, Issue 5, 2010, Pages 589-594

  Zhang, Xiu Min ^a   Gao, Ning ^a   Chen, Ru Xian ^a   Xu, Hong Zhang ^a   He, Qi Yang ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Antitumor effect; Apoptosis; Bleomycin family; Boningmycin; Cellular senescence

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BACTERIAL PROTEIN; BETA GALACTOSIDASE; BONINGMYCIN; DOXORUBICIN; NITROBLUE TETRAZOLIUM; P21 ACTIVATED KINASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL AGING; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CLONOGENESIS; EPITHELIUM TUMOR; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUTH MUCOSA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STREPTOMYCES; STREPTOMYCES VERTICILLUS; TUMOR CELL; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLEOMYCIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL AGING; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; HUMANS; KB CELLS; LUNG NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954619438     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Xu HZ, Yu L, Zhang XR, et al. Isolation, purification and structure determination of boningmycin (Z-893) [J]. Chin J Antibio, 2003, 28: 465-467.
2. Qi CM, Xu HZ, Chen RX. The efficacy observation of boningmycin cream on cow papilloma induced by cow papilloma virus [J]. Chin J Antibio, 2003, 28: 568-570.
3. Hanahan D, Weinberg RA. The hallmarks of cancer [J]. Cell, 2000, 100: 57-70.
4. Schmitt CA, Fridman JS, Yang M, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy [J]. Cell, 2002, 109: 335-346. (Pubitemid 34606876)
5. Chang BD, Xuan Y, Broude EV, et al. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs [J]. Oncogene, 1999, 18: 4808-4818. (Pubitemid 29423564)
6. Eom YW, Kim MA, Park SS, et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype [J]. Oncogene, 2005, 24: 4765-4777.
7. He QY, Liang YY, Wang DS, et al. Characteristics of mitotic cell death induced by enediyne antibiotic lidamycin in human epithelial tumor cells [J]. Int J Oncol, 2002, 20: 261-266.
8. Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumor cells [J]. Nat Rev Cancer, 2004, 4: 592-603. (Pubitemid 39025054)
9. Rebbaa A, Zheng X, Chou PM, et al. Caspase inhibition switches doxorubicin-induced apoptosis to senescence [J]. Oncogene, 2003, 22: 2805-2811. (Pubitemid 36609594)
10. Robles SJ, Adami GR. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts [J]. Oncogene, 1998, 16: 1113-1123.
11. Aoshiba K, Tsuji T, Nagai A. Bleomycin induces cellular senescence in alveolar epithelial cells [J]. Eur Respir J, 2003, 22: 436-443. (Pubitemid 37098924)
12. Hou Y, Bao XQ, Liu GT. The role of vitagene in aging and Alzheimer's disease and relevant advances of pharmacological study [J]. Acta Pharm Sin, 2009, 44: 825-832.
13. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging [J]. Cell, 2005, 120: 483-495.
14. Song YS, Lee BY, Hwang ES. Distinct ROS and biochemical profiles in cells undergoing DNA damage-induced senescence and apoptosis [J]. Mech Age Dev, 2005, 126: 580-590.
15. 1 arrest but not cell replication [J]. Biochem J, 1998, 332: 43-50. (Pubitemid 28239316)
16. Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi [J]. Nature, 2005, 436: 720-724. (Pubitemid 41117276)
17. Campisi J. Suppressing cancer: the importance of being senescent [J]. Science, 2005, 309: 886-887.
18. Braig M, Lee S, Loddenkemper C, et al. Oncogene-induced senescence as an initial barrier in lymphoma development [J]. Nature, 2005, 436: 660-665.
19. Zhu YJ, Jiang FC. Progress in the study of antitumor drug targeting on the Ras signaling pathway [J]. Acta Pharm Sin, 2009, 44: 1-10.